![Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer - ScienceDirect Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610822005487-fx1.jpg)
Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer - ScienceDirect
![IJTM | Free Full-Text | Non-Clear Cell Renal Cell Carcinoma: Molecular Pathogenesis, Innovative Modeling, and Targeted Therapeutic Approaches IJTM | Free Full-Text | Non-Clear Cell Renal Cell Carcinoma: Molecular Pathogenesis, Innovative Modeling, and Targeted Therapeutic Approaches](https://pub.mdpi-res.com/ijtm/ijtm-02-00042/article_deploy/html/images/ijtm-02-00042-g001.png?1669219133)
IJTM | Free Full-Text | Non-Clear Cell Renal Cell Carcinoma: Molecular Pathogenesis, Innovative Modeling, and Targeted Therapeutic Approaches
![Diseases | Free Full-Text | Proficient Novel Biomarkers Guide Early Detection of Acute Kidney Injury: A Review Diseases | Free Full-Text | Proficient Novel Biomarkers Guide Early Detection of Acute Kidney Injury: A Review](https://www.mdpi.com/diseases/diseases-11-00008/article_deploy/html/images/diseases-11-00008-g001.png)
Diseases | Free Full-Text | Proficient Novel Biomarkers Guide Early Detection of Acute Kidney Injury: A Review
![Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02026-1/MediaObjects/13046_2021_2026_Fig22_HTML.png)
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
![The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions - ScienceDirect The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2090123219301560-ga1.jpg)
The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions - ScienceDirect
![Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma | Nature Reviews Clinical Oncology Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41571-020-00455-z/MediaObjects/41571_2020_455_Fig1_HTML.png)
Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma | Nature Reviews Clinical Oncology
![Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade - ScienceDirect Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610820305420-fx1.jpg)
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade - ScienceDirect
![Biomarker discovery for renal cancer stem cells - Corrò - 2018 - The Journal of Pathology: Clinical Research - Wiley Online Library Biomarker discovery for renal cancer stem cells - Corrò - 2018 - The Journal of Pathology: Clinical Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3a97f13a-83cc-44e9-8788-b2d4a966a052/cjp291-fig-0002-m.jpg)
Biomarker discovery for renal cancer stem cells - Corrò - 2018 - The Journal of Pathology: Clinical Research - Wiley Online Library
![Biomarkers in renal cell carcinoma: Towards a more selective immune checkpoint inhibition - ScienceDirect Biomarkers in renal cell carcinoma: Towards a more selective immune checkpoint inhibition - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936523321000632-fx1.jpg)
Biomarkers in renal cell carcinoma: Towards a more selective immune checkpoint inhibition - ScienceDirect
![Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma | Nature Reviews Urology Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma | Nature Reviews Urology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41585-022-00676-0/MediaObjects/41585_2022_676_Fig1_HTML.png)
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma | Nature Reviews Urology
![Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma - ScienceDirect Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610821001173-fx1.jpg)
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma - ScienceDirect
![Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02026-1/MediaObjects/13046_2021_2026_Fig5_HTML.png)